PriceTargets.com logo

British American Tobacco - BATS Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: GBX 3,183.33
  • Forecasted Upside: 1.74%
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
GBX 3,129 As of 03/28/2025 01:41 PM ET
▲ +24 (0.77%)

This chart shows the closing price for BATS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
FebMar3,129.00Closing price on 03/28/25:
Get New British American Tobacco Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BATS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BATS

Analyst Price Target is GBX 3,183.33
▲ +1.74% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for British American Tobacco in the last 3 months. The average price target is GBX 3,183.33, with a high forecast of GBX 3,450 and a low forecast of GBX 2,800. The average price target represents a 1.74% upside from the last price of GBX 3,129.

This chart shows the closing price for BATS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart
3/246/249/2412/243/254/261.59k2.12k2.66k3.20k3.73kClosing price on 03/28/25: 3,129.00High3.45kAverage3.18kLow2.80k




Current Consensus is Moderate Buy

The current consensus among 3 investment analysts is to moderate buy stock in British American Tobacco. This rating has held steady since May 2024, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
10/6/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
1/4/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
4/3/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
7/2/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
9/30/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/29/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
2/27/2025
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
3/29/2025

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/12/2024JPMorgan Chase & Co.Reiterated RatingNeutralGBX 2,800
5/21/2024Deutsche Bank AktiengesellschaftLower TargetBuyGBX 4,000 ➝ GBX 3,450
4/22/2024Jefferies Financial GroupReiterated RatingBuyGBX 3,300
12/14/2023JPMorgan Chase & Co.Reiterated RatingNeutralGBX 2,700
11/24/2023Royal Bank of CanadaReiterated RatingSector PerformGBX 3,500
11/15/2023Jefferies Financial GroupReiterated RatingBuyGBX 4,100
3/24/2023Jefferies Financial GroupReiterated RatingBuyGBX 4,100
3/13/2023JPMorgan Chase & Co.DowngradeNeutralGBX 3,600 ➝ GBX 3,100
2/28/2023JPMorgan Chase & Co.Reiterated RatingOverweightGBX 3,600
2/27/2023Jefferies Financial GroupSet TargetGBX 4,100
2/14/2023BarclaysReiterated RatingOverweightGBX 4,000
2/13/2023JPMorgan Chase & Co.Lower TargetOverweightGBX 4,000 ➝ GBX 3,600
2/13/2023Credit Suisse GroupSet TargetGBX 3,900
2/10/2023Deutsche Bank AktiengesellschaftSet TargetGBX 4,000
2/10/2023Royal Bank of CanadaSet TargetGBX 3,500
2/9/2023JPMorgan Chase & Co.Set TargetGBX 4,000
2/9/2023The Goldman Sachs GroupSet TargetGBX 3,500
2/6/2023Credit Suisse GroupSet TargetGBX 4,050
1/31/2023Jefferies Financial GroupSet TargetGBX 4,700
1/31/2023JPMorgan Chase & Co.Set TargetGBX 4,000
1/30/2023The Goldman Sachs GroupSet TargetGBX 3,800
1/11/2023The Goldman Sachs GroupSet TargetGBX 3,800
1/11/2023JPMorgan Chase & Co.Set TargetGBX 4,000
1/2/2023The Goldman Sachs GroupSet TargetGBX 3,800
12/27/2022The Goldman Sachs GroupSet TargetGBX 3,800
12/21/2022The Goldman Sachs GroupSet TargetGBX 3,800
12/13/2022Credit Suisse GroupSet TargetGBX 4,050
12/9/2022UBS GroupSet TargetGBX 4,100
12/9/2022Deutsche Bank AktiengesellschaftSet TargetGBX 4,000
12/8/2022Jefferies Financial GroupSet TargetGBX 4,800
12/8/2022JPMorgan Chase & Co.Set TargetGBX 4,000
12/1/2022BarclaysReiterated RatingOverweightGBX 4,500
12/1/2022JPMorgan Chase & Co.Set TargetGBX 4,000
11/22/2022The Goldman Sachs GroupSet TargetGBX 3,800
11/2/2022The Goldman Sachs GroupSet TargetGBX 3,800
10/3/2022Jefferies Financial GroupSet TargetGBX 4,800
9/28/2022Credit Suisse GroupSet TargetGBX 4,300
8/30/2022BarclaysBoost TargetOverweightGBX 4,400 ➝ GBX 4,500
8/17/2022Jefferies Financial GroupSet TargetGBX 4,500
8/3/2022BarclaysReiterated RatingOverweightGBX 4,400
7/28/2022JPMorgan Chase & Co.Reiterated RatingOverweightGBX 4,500
7/28/2022Royal Bank of CanadaBoost TargetSector PerformGBX 3,100 ➝ GBX 3,500
7/26/2022CitigroupReiterated RatingBuyGBX 3,900
7/25/2022Jefferies Financial GroupSet TargetGBX 4,300
7/21/2022Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 4,000
7/15/2022JPMorgan Chase & Co.Boost TargetOverweightGBX 4,000 ➝ GBX 4,500
6/28/2022BarclaysReiterated RatingOverweightGBX 4,400
6/28/2022Morgan StanleySet TargetGBX 3,780
6/23/2022JPMorgan Chase & Co.Reiterated RatingOverweightGBX 4,000
6/17/2022The Goldman Sachs GroupSet TargetGBX 4,000
6/10/2022Deutsche Bank AktiengesellschaftSet TargetGBX 4,000
6/9/2022JPMorgan Chase & Co.Set TargetGBX 4,000
6/9/2022The Goldman Sachs GroupSet TargetGBX 4,000
6/1/2022Royal Bank of CanadaReiterated RatingSector PerformGBX 3,100
5/30/2022BarclaysReiterated RatingOverweight
5/25/2022The Goldman Sachs GroupSet TargetGBX 4,000
5/11/2022Morgan StanleyReiterated RatingOverweight
5/6/2022BarclaysReiterated RatingOverweight
5/4/2022Royal Bank of CanadaReiterated RatingSector PerformGBX 3,100
4/27/2022JPMorgan Chase & Co.Set TargetGBX 4,000
4/24/2022Morgan StanleyReiterated RatingOverweightGBX 3,780
4/20/2022BarclaysReiterated RatingOverweight
4/14/2022Morgan StanleyReiterated RatingOverweight
4/8/2022The Goldman Sachs GroupSet TargetGBX 3,800
4/7/2022UBS GroupSet TargetGBX 3,600
4/1/2022Royal Bank of CanadaReiterated RatingSector PerformGBX 3,100
3/25/2022Morgan StanleyReiterated RatingOverweight
3/24/2022JPMorgan Chase & Co.Set TargetGBX 4,000
3/17/2022Royal Bank of CanadaSet TargetGBX 3,100
3/15/2022CitigroupLower TargetBuyGBX 3,750 ➝ GBX 3,675
3/14/2022JPMorgan Chase & Co.Reiterated RatingNeutral
3/11/2022JPMorgan Chase & Co.Set TargetGBX 3,550
3/10/2022Jefferies Financial GroupSet TargetGBX 3,900
3/9/2022Morgan StanleyReiterated RatingOverweight
3/8/2022BarclaysReiterated RatingOverweightGBX 4,200
2/15/2022JPMorgan Chase & Co.Boost TargetNeutralGBX 3,100 ➝ GBX 3,550
2/15/2022BarclaysBoost TargetOverweightGBX 3,400 ➝ GBX 4,200
2/14/2022Deutsche Bank AktiengesellschaftSet TargetGBX 4,000
2/14/2022The Goldman Sachs GroupSet TargetGBX 3,800
2/11/2022Royal Bank of CanadaDowngradeSector PerformGBX 3,300
2/11/2022JPMorgan Chase & Co.Set TargetGBX 3,100
2/11/2022Jefferies Financial GroupSet TargetGBX 3,900
2/9/2022Morgan StanleyReiterated RatingOverweight
2/8/2022Deutsche Bank AktiengesellschaftReiterated RatingBuy
1/29/2022Morgan StanleyReiterated RatingOverweight
1/28/2022JPMorgan Chase & Co.Set TargetGBX 3,100
1/25/2022Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 4,000
1/21/2022The Goldman Sachs GroupSet TargetGBX 3,700
1/18/2022Royal Bank of CanadaSet TargetGBX 3,300
1/17/2022Jefferies Financial GroupSet TargetGBX 3,900
1/10/2022BarclaysBoost TargetOverweightGBX 3,300 ➝ GBX 3,400
1/4/2022Royal Bank of CanadaSet TargetGBX 3,300
12/20/2021CitigroupReiterated RatingBuyGBX 3,250
12/13/2021The Goldman Sachs GroupSet TargetGBX 3,700
12/8/2021Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 4,000
12/7/2021The Goldman Sachs GroupSet TargetGBX 3,700
12/7/2021JPMorgan Chase & Co.Reiterated RatingNeutralGBX 3,100
12/3/2021BarclaysReiterated RatingOverweightGBX 3,300
11/30/2021JPMorgan Chase & Co.Set TargetGBX 3,100
11/15/2021Morgan StanleyReiterated RatingOverweight
11/9/2021Jefferies Financial GroupSet TargetGBX 3,769
10/19/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
10/13/2021BarclaysReiterated RatingOverweightGBX 3,300
9/13/2021JPMorgan Chase & Co.Set TargetGBX 3,400
8/3/2021Morgan StanleyBoost TargetOverweightGBX 3,130 ➝ GBX 3,210
7/30/2021JPMorgan Chase & Co.Boost TargetNeutralGBX 3,100 ➝ GBX 3,400
7/29/2021Deutsche Bank AktiengesellschaftSet TargetGBX 4,000
7/28/2021Royal Bank of CanadaReiterated RatingOutperformGBX 3,200
7/28/2021JPMorgan Chase & Co.Set TargetGBX 3,100
7/28/2021Jefferies Financial GroupSet TargetGBX 3,606
7/28/2021The Goldman Sachs GroupSet TargetGBX 3,700
7/27/2021BarclaysReiterated RatingOverweightGBX 3,300
7/2/2021Royal Bank of CanadaSet TargetGBX 3,200
6/29/2021CitigroupReiterated RatingBuy
6/28/2021BarclaysReiterated RatingOverweightGBX 3,300
6/22/2021JPMorgan Chase & Co.Set TargetNeutralGBX 3,100
6/14/2021JPMorgan Chase & Co.Set TargetNeutralGBX 3,100
6/14/2021The Goldman Sachs GroupSet TargetBuyGBX 3,700
6/8/2021JPMorgan Chase & Co.Reiterated RatingNeutralGBX 3,100
6/8/2021The Goldman Sachs GroupReiterated RatingBuyGBX 3,700
4/28/2021The Goldman Sachs GroupSet TargetBuyGBX 3,700
4/20/2021The Goldman Sachs GroupSet TargetBuyGBX 3,700
4/9/2021JPMorgan Chase & Co.Reiterated RatingNeutralGBX 3,100
3/26/2021Jefferies Financial GroupReiterated RatingBuyGBX 3,606
3/24/2021Credit Suisse GroupSet TargetBuyGBX 4,100
3/18/2021BarclaysLower TargetOverweightGBX 3,800 ➝ GBX 3,300
3/2/2021JPMorgan Chase & Co.Set TargetBuyGBX 3,500
2/19/2021UBS GroupReiterated RatingBuyGBX 3,600
2/18/2021Deutsche Bank AktiengesellschaftSet TargetBuyGBX 4,000
2/17/2021Credit Suisse GroupSet TargetBuyGBX 3,920
2/17/2021Jefferies Financial GroupSet TargetNeutralGBX 2,792
2/17/2021JPMorgan Chase & Co.Set TargetBuyGBX 3,500
2/17/2021The Goldman Sachs GroupSet TargetBuyGBX 3,900
2/17/2021Royal Bank of CanadaSet TargetBuyGBX 3,200
2/11/2021Credit Suisse GroupSet TargetBuyGBX 3,920
2/10/2021Credit Suisse GroupBoost TargetOutperformGBX 3,920 ➝ GBX 4,000
1/20/2021Jefferies Financial GroupReiterated RatingNeutralGBX 2,792
1/12/2021UBS GroupSet TargetBuyGBX 3,800
1/8/2021JPMorgan Chase & Co.Set TargetBuyGBX 3,500
1/4/2021Royal Bank of CanadaSet TargetBuyGBX 3,200
12/17/2020JPMorgan Chase & Co.Set TargetBuyGBX 3,500
12/16/2020Royal Bank of CanadaSet TargetBuyGBX 3,200
12/15/2020The Goldman Sachs GroupReiterated RatingBuyGBX 3,900
12/10/2020Credit Suisse GroupSet TargetBuyGBX 4,000
12/8/2020Jefferies Financial GroupReiterated RatingNeutralGBX 2,909
12/3/2020JPMorgan Chase & Co.Set TargetBuyGBX 3,500
12/3/2020Credit Suisse GroupReiterated RatingBuyGBX 4,000
11/25/2020The Goldman Sachs GroupReiterated RatingBuyGBX 3,870
11/4/2020Credit Suisse GroupReiterated RatingBuyGBX 4,100
11/3/2020The Goldman Sachs GroupReiterated RatingBuyGBX 3,870
10/6/2020JPMorgan Chase & Co.Set TargetBuyGBX 3,500
9/22/2020Royal Bank of CanadaUpgradeOutperformGBX 3,200
9/2/2020Morgan StanleyLower TargetOverweightGBX 3,380 ➝ GBX 3,330
8/17/2020Jefferies Financial GroupLower TargetHoldGBX 3,000 ➝ GBX 2,700
8/7/2020JPMorgan Chase & Co.Set TargetBuyGBX 3,500
8/4/2020Credit Suisse GroupReiterated RatingBuyGBX 3,930
8/3/2020Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 4,000
7/31/2020The Goldman Sachs GroupSet TargetBuyGBX 4,000
7/31/2020Royal Bank of CanadaReiterated RatingNeutralGBX 2,700
7/31/2020JPMorgan Chase & Co.Set TargetBuyGBX 4,250
7/31/2020Liberum CapitalReiterated RatingBuy
7/29/2020BarclaysReiterated RatingOverweight
7/27/2020UBS GroupReiterated RatingBuy
7/24/2020Royal Bank of CanadaBoost TargetSector PerformerGBX 2,600 ➝ GBX 2,700
7/20/2020Jefferies Financial GroupDowngradeHoldGBX 4,800 ➝ GBX 3,000
7/9/2020UBS GroupReiterated RatingBuyGBX 3,200 ➝ GBX 3,800
7/8/2020Morgan StanleyReiterated RatingBuy
7/8/2020BarclaysLower TargetOverweightGBX 4,200 ➝ GBX 3,800
7/7/2020Morgan StanleyBoost TargetOverweightGBX 3,200 ➝ GBX 3,380
7/3/2020Credit Suisse GroupSet TargetBuyGBX 4,070
7/1/2020The Goldman Sachs GroupInitiated CoverageBuyGBX 4,000
6/29/2020Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 4,000
6/18/2020CitigroupReiterated RatingBuy
6/15/2020JPMorgan Chase & Co.Set TargetBuyGBX 4,250
6/10/2020UBS GroupReiterated RatingBuyGBX 3,200
6/10/2020Credit Suisse GroupReiterated RatingOutperform
6/10/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
6/10/2020BarclaysReiterated RatingOverweight
6/10/2020Liberum CapitalReiterated RatingBuy
6/10/2020Jefferies Financial GroupSet TargetBuyGBX 4,800
6/9/2020Credit Suisse GroupSet TargetBuyGBX 4,070
6/9/2020JPMorgan Chase & Co.Set TargetBuyGBX 4,250
6/9/2020Royal Bank of CanadaReiterated RatingNeutralGBX 2,600
6/4/2020Jefferies Financial GroupReiterated RatingBuyGBX 4,800
6/4/2020BarclaysReiterated RatingOverweight
4/30/2020JPMorgan Chase & Co.Set TargetBuyGBX 4,250
4/30/2020Liberum CapitalReiterated RatingBuy
4/20/2020Royal Bank of CanadaLower TargetSector PerformerGBX 3,100 ➝ GBX 2,600
4/16/2020UBS GroupReiterated RatingBuy
4/15/2020Credit Suisse GroupLower TargetOutperformGBX 4,250 ➝ GBX 4,070
4/14/2020Liberum CapitalReiterated RatingBuy
4/8/2020Morgan StanleyUpgradeOverweight
4/2/2020UBS GroupReiterated RatingBuyGBX 3,200
(Data available from 3/29/2020 forward)

News Sentiment Rating

0.52 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 16 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/31/2024
  • 5 very positive mentions
  • 13 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/30/2024
  • 3 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/30/2024
  • 7 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/29/2024
  • 4 very positive mentions
  • 11 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
Mentions as of
12/29/2024
  • 4 very positive mentions
  • 11 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
1/28/2025
  • 4 very positive mentions
  • 37 positive mentions
  • 10 negative mentions
  • 3 very negative mentions
Mentions as of
2/27/2025
  • 3 very positive mentions
  • 11 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
3/29/2025

Current Sentiment

  • 3 very positive mentions
  • 11 positive mentions
  • 3 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

British American Tobacco logo
BAT was founded in 1902 and was first listed on the London Stock Exchange in 1912. A constituent of the FTSE 100 since its creation in 1984, we have evolved, becoming the only truly global company in our sector. BAT is transforming and is well positioned with a global footprint and multi-category portfolio. Our corporate purpose is to build A Better Tomorrow™, reducing the health impact of our business, by offering adult consumers a greater choice of enjoyable and less risky*† products compared to cigarettes. To accelerate the next phase of our transformation journey, we are now committed to Building a Smokeless^ World and becoming a predominantly smokeless business by 2035. In addition to our purpose to reduce the health impact of our business, we continue to integrate and embed sustainability throughout our organisation, addressing areas of material impact including climate change, circular economy, biodiversity and human rights. We have a global portfolio of established brands in five categories: Vapour (Vuse), Heated Products (Glo), Modern Oral (Velo), Traditional Oral (Grizzly) and Cigarettes (including Dunhill, Kent, Lucky Strike, Rothmans and Pall Mall). Our products are sold in over 150 markets, across six continents, through over 11 million points of sale. In addition, we continue to seek longer term opportunities in adjacent areas Beyond Nicotine focused on wellbeing and simulation. BAT employs over 46,000 people and generates over £27bn total revenue** across our three regions: - The United States of America - Americas & Europe (AME) - Asia Pacific, Middle East & Africa (APMEA) BAT is highly cash generative – we have returned c.£26bn of cash to shareholders (from 2019—2023) and expect to generate around £40bn*** free cash flow before dividends over the next 5 years. Going forward the key elements of capital allocation at BAT will include: - Continued investment in our transformation - Progressive dividends – building on our 25-year track record of consistent growth - Continued deleverage to a range of 2-2.5x adjusted net debt / adjusted EBITDA - Sustainable share buybacks (starting with £1.6bn by December 2025)**** We have strong foundations, and a strategy for accelerated growth. We are confident this will create sustainable value for all our stakeholders. For more information, please visit www.bat.com/investors. March 2024 * Based on the weight of evidence and assuming a complete switch from cigarette smoking. These products are not risk free and are addictive. † Our Vapour product Vuse (including Alto, Solo, Ciro and Vibe), and certain products, including Velo, Grizzly, Kodiak, and Camel Snus, which are sold in the U.S., are subject to FDA regulation and no reduced-risk claims will be made as to these products without agency clearance. ^ Smokeless – refers to non-combustibles, including Vapour products, Heated Products, Modern Oral pouches and Traditional Oral. ** FY23 at current rates *** Cumulative free cash flow. **** Forward-looking statements involve risk and uncertainties and undue reliance should not be placed on such statements. Please see cautionary statement in our current annual report in Form 20-F: BAT 2023 ARA - Form 20F
Read More

Today's Range

Now: GBX 3,129
Low: 3,109
High: 3,142

50 Day Range

MA: GBX 3,132.27
Low: 2,953
High: 3,394

52 Week Range

Now: GBX 3,129
Low: 2,228.78
High: 3,416

Volume

14,652,567 shs

Average Volume

17,436,309 shs

Market Capitalization

£68.84 billion

P/E Ratio

N/A

Dividend Yield

7.61%

Beta

0.27

Frequently Asked Questions

What sell-side analysts currently cover shares of British American Tobacco?

The following Wall Street analysts have issued research reports on British American Tobacco in the last year: Deutsche Bank Aktiengesellschaft, Jefferies Financial Group Inc., and JPMorgan Chase & Co..
View the latest analyst ratings for BATS.

What is the current price target for British American Tobacco?

0 Wall Street analysts have set twelve-month price targets for British American Tobacco in the last year. Their average twelve-month price target is GBX 3,183.33, suggesting a possible upside of 1.7%. Deutsche Bank Aktiengesellschaft has the highest price target set, predicting BATS will reach GBX 3,450 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of GBX 2,800 for British American Tobacco in the next year.
View the latest price targets for BATS.

What is the current consensus analyst rating for British American Tobacco?

British American Tobacco currently has 1 hold rating and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for BATS.

What other companies compete with British American Tobacco?

Other companies that are similar to British American Tobacco include Imperial Brands, Unilever, Diageo, Coca-Cola Europacific Partners and Reckitt Benckiser Group. Learn More about companies similar to British American Tobacco.

How do I contact British American Tobacco's investor relations team?

British American Tobacco's physical mailing address is Globe House, 4 Temple Place, LONDON, WC2R 2PG, United Kingdom. The company's listed phone number is +44-20-78452000. The official website for British American Tobacco is www.bat.com. Learn More about contacing British American Tobacco investor relations.